SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 155 filers reported holding SERES THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $410,316 | +640.8% | 85,661 | +777.0% | 0.00% | – |
| Q1 2023 | $55,385 | -85.1% | 9,768 | -85.2% | 0.00% | -100.0% |
| Q4 2022 | $370,720 | +36972.0% | 66,200 | +35491.4% | 0.00% | – |
| Q3 2022 | $1,000 | -93.8% | 186 | -96.1% | 0.00% | – |
| Q2 2022 | $16,000 | -94.9% | 4,752 | -89.1% | 0.00% | -100.0% |
| Q1 2022 | $311,000 | -87.0% | 43,639 | -84.8% | 0.00% | -87.0% |
| Q4 2021 | $2,394,000 | +8.1% | 287,402 | -9.7% | 0.02% | -17.9% |
| Q3 2021 | $2,215,000 | +235.6% | 318,190 | +1049.1% | 0.03% | +300.0% |
| Q2 2021 | $660,000 | +68.8% | 27,691 | +73.6% | 0.01% | +40.0% |
| Q4 2020 | $391,000 | -81.3% | 15,947 | -78.4% | 0.01% | -83.9% |
| Q3 2020 | $2,086,000 | +1813.8% | 73,667 | +222.2% | 0.03% | +1450.0% |
| Q2 2020 | $109,000 | -35.9% | 22,864 | +116.3% | 0.00% | -80.0% |
| Q3 2017 | $170,000 | – | 10,572 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 12,682,876 | $142,936,000 | 37.99% |
| ARK Investment Management | 629,915 | $7,099,000 | 2.05% |
| Artal Group S.A. | 600,000 | $6,762,000 | 0.15% |
| Rock Springs Capital Management LP | 220,000 | $2,479,000 | 0.14% |
| Opus Point Partners Management, LLC | 14,000 | $158,000 | 0.12% |
| HAMILTON LANE ADVISORS LLC | 14,883 | $168,000 | 0.08% |
| Virtus ETF Advisers LLC | 31,133 | $351,000 | 0.06% |
| FOX RUN MANAGEMENT, L.L.C. | 12,100 | $136,000 | 0.06% |
| Acrospire Investment Management LLC | 4,470 | $50,000 | 0.04% |
| Spark Investment Management LLC | 54,400 | $613,000 | 0.04% |